Pt Eisai Indonesia company information, Employees & Contact Information

Eisai Co. Evaluates Fycompa’s Safety in New Clinical Study TipRanks

History of Enhancing the Company's Corporate Governance Eisai

What dividend safety rating applies to Eisai Co. Ltd. (EII) stock - Fed Meeting & Long Hold Capital Preservation Tips Fundação Cultural do Pará

Eisai Co.’s Tasurgratinib Study: Key Insights for Investors TipRanks

Will Eisai Co. Ltd. (EII) stock keep high P E multiples - 2025 Price Momentum & Daily Profit Maximizing Tips Trung tâm Dự báo KTTV quốc gia

Social Impact Creation Model Eisai

Why It Might Not Make Sense To Buy Eisai Co., Ltd. (TSE:4523) For Its Upcoming Dividend simplywall.st

Eisai Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:ESALF) 2025-08-05 Seeking Alpha

Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories Yahoo Finance

Prevention of Environmental Pollution Eisai

Eisai Limited Bolsters Canadian Operations with Major Mississauga Expansion PR Newswire Canada

Recycling of resources Eisai

Eisai Co. Surpasses FY 2024 Expectations Amid Challenges TipRanks

EISAI COMPLETES CONSTRUCTION OF ITS NEW INJECTION/RESEARCH BUILDING AT KAWASHIMA INDUSTRIAL PARK IN JAPAN | News Release：2022 Eisai

The First 80 Years | Eisai Co., Ltd. Eisai

Dementia Eisai

hhceco (the hhc Concept + ecosystem) | Innovation Eisai

Compliance and Risk Management Eisai

Corporate Venture Capital Eisai

Message from Top Management Eisai

Production and Logistics (Demand Chain Systems) Eisai

Initiatives for Improving Access to Medicines Eisai

Alzheimer's Disease Treatment The Aricept R&D Story Eisai

Simmons & Simmons advises Eisai Co., Ltd. on the sale to H.A.C. Simmons & Simmons

EISAI LAUNCHES REDESIGNED CORPORATE WEBSITE Eisai

Corporate Governance System and Features Eisai

Chapter 6 Breaking into the Top 20 Worldwide Eisai

Flow of R&D (Drug Creation Research) | Research and Development (R&D) Eisai

Eisai's Founder, Toyoji Naito Part II Eisai

Chapter 7 An Ambitious Leap Forward Eisai

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments Biogen

Eisai co-establishes “Global Health Innovative Technology Fund,” Japan's first public–private partnership to eliminate infectious disease in developing countries | Research & Development for Improving Access to Medicines Eisai

Biogen and Eisai Announce FDA’s 3-Month Extension of Review Period for the Biologics License Application for Aducanumab Biogen

Eisai, Biogen Alzheimer's drug could be available to some next year Reuters

Merck, Eisai discontinue late-stage study for combo cancer therapy Reuters

Shares of Japan's Eisai tumble after EU rejects Alzheimer's drug Reuters

Eisai seeks FDA approval for at-home Alzheimer’s treatment option Investing.com

Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting PR Newswire

Eisai files for approval of Alzheimer's drug in Japan Reuters

Is Eisai Co. Ltd. (EII) stock undervalued by metrics - July 2025 Gainers & Weekly Return Optimization Alerts newser.com

Is Eisai Co. Ltd. (EII) stock positioned for digital growth era - Bond Market & Capital Protection Trading Alerts newser.com

Eisai and Biogen Self-Injected Alzheimer Drug Wins US Approval Bloomberg.com

SEED Therapeutics (SEED) Enters into Strategic Research GlobeNewswire

Biogen and Eisai Expand Existing Collaboration Agreement to Develop and Commercialize Investigational Alzheimer’s Disease Treatments Including Phase 3 Aducanumab Biogen

What dividend safety rating applies to Eisai Co. Ltd. (EII) stock - 2025 Trading Recap & Real-Time Stock Entry Alerts Trung tâm Dự báo KTTV quốc gia

Is Eisai Co. Ltd. (EII) stock a buy before new product rollout - Market Trend Summary & Detailed Earnings Play Alerts newser.com

UBS Maintains EISAI CO LTD(ESALF.US) With Buy Rating, Cuts Target Price to $34.79 富途牛牛

Eisai Stock: Leqembi Approved In EU (OTCMKTS:ESALF) Seeking Alpha

Eisai Co.’s Promising Study on E7386: A Game Changer in Cancer Treatment? TipRanks

Eisai, Biogen start U.S. accelerated approval for new Alzheimer's drug Reuters

Is Eisai Co. Ltd. (EII) stock positioned for digital growth era - Swing Trade & Community Verified Trade Signals newser.com

Is Eisai Co. Ltd. (EII) stock positioned for digital growth era - Short Setup & Weekly Market Pulse Updates newser.com

Alzheimers Drugs Market Projected To Reach USD 12.26 Bn by GlobeNewswire

Is Eisai Co. Ltd. (EII) stock a buy before new product rollout - Market Trend Summary & Fast Gain Swing Alerts newser.com

Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drug Financial Times

Eisai Co.’s E1018 Study: A Potential Game-Changer in Malaria Treatment TipRanks

Jefferies Maintains EISAI CO LTD(ESALF.US) With Hold Rating, Cuts Target Price to $29.15 富途牛牛

Eisai expands direct presence in Saudi Arabia with new pharma sales subsidiary BioSpectrum Asia

Alzheimer’s drug co-developed by Eisai approved for use in Japan 朝日新聞

Eisai dissolves joint venture with Bracco Imaging Medical Dialogues

Eisai Alzheimer’s drug and clot buster seen as cause of brain hemorrhage death -analysis 朝日新聞

Asterand Signs Agreement with Eisai Co. Technology Networks

Pharmaceutical Giant Eisai Hit by Ransomware Attack The Japan News

Eisai Limited celebrates opening of new Canadian headquarters PR Newswire Canada

What drives Eisai Co Ltd EII stock price - Market Sentiment Indicators & Big Gains Small Budget earlytimes.in

Japanese drug maker Eisai buys MGI Pharma NBC News

Eisai Co. Licenses Protein Expression Data Analysis System from Rosetta Biosoftware Technology Networks